具有双囊壁的温度敏感香味微囊:关于制备和持续释放机制的研究
Qun Yang1,2, Genghao Hu1, Huili Qiu1
1School of Textiles and Fashion, Shanghai University of Engineering Science, Shanghai 201620, China.
Polymers
|September 28, 2023
概括
开发了具有温度敏感外墙的双壁微囊,用于控制香气释放. 这些微囊提供增强的稳定性和持续的气味释放,非常适合夏季服装应用.
科学领域:
- 材料科学 材料科学 材料科学
- 聚合物化学 聚合物化学
- 织品化学 织品化学
背景情况:
- 微囊保护核心材料免受降解,双壁结构提供更好的稳定性和功能.
- 温度敏感的微囊可以控制活性成分的释放,提高产品的适用性.
- 凝和阿拉伯糖-N-异烯胺 (NIPAM) 复合物被探索用于双壁微囊制造.
研究的目的:
- 为了合成和表征用于香气传递的双壁微.
- 为了研究阿拉伯糖与NIPAM比率对微囊性质的影响.
- 为了评估香水微囊的稳定性,释放特性和应用.
主要方法:
- 采用复杂的凝聚方法来制造双壁微囊.
- 凝作为内墙,而阿拉伯糖和N-异烯胺 (NIPAM) 的复合物形成了外墙.
- 描述包括分析核心负荷,产量,热稳定性,溶剂/pH稳定性和棉织物持续释放的分析.
主要成果:
- 用NIPAM与阿拉伯糖的比率为10:1制备的微囊表现出最佳的温度反应性.
- 双墙结构增强了微囊的稳定性,并提供了可控释放的衣草香油.
- 经过处理的棉织物表现出持续的香味释放,特别是在应对温度变化时.
结论:
- 使用凝和阿拉伯糖-NIPAM复合物的双壁微囊对受控的香味传递是有效的.
- 开发的微囊提供了增强的稳定性和温度触发释放,适用于织应用.
- 这项技术可以为服装提供持久的新鲜气味,特别是在温暖的天气条件下.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
01:20Modified-Release Drug Delivery Systems: Influencing Factors
200
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
200
01:23Modified-Release Drug Delivery Systems: Classification
309
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
309
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
168
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
168
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
172
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
172
01:11Oral Drug Delivery Systems: Delayed-Release Systems
206
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
206